Intestinal regulation of oxalate absorption is a complex mechanism, not exclusively reliant on the oxalate-degrading anaerobe Oxalobacter formigenes.
Minerva Neurosciences, Inc. a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, announced that the FDA filed the Company’s New Drug Application (NDA) for roluperidone for the treatment of negative symptoms in patients with schizophrenia on April 27, 2023
Radius Health has announced that positive results from the Phase III ACTIVE trial of BA 058 (abaloparatide) in osteoporosis were...
Objectives: To test the efficacy of adalimumab in HS.
It is challenging to estimate a true prevalence of hidradenitis suppurativa (HS) because it is underdiagnosed and misdiagnosed.
A new meta-analysis of 29 studies involving more than 4,500 patients with Knee Osteoarthritis found that intra-articular hyaluronic acid (HA)...
This paper summarizes the clinical evidence that lead to the recent approval of the combination of dabrafenib and trametinib to treat patients with advanced NSCLC who harbor a BRAF V600E mutation.
Background: Powered exoskeletons are designed to safely facilitate ambulation in patients with spinal cord injury (SCI). We conducted the first meta-analysis of the available published research on the clinical effectiveness and safety of powered exoskeletons in SCI patients.
Here we discuss the current knowledge on dry AMD pathobiology and propose future research directions that would expedite the development of new treatments.
Amgen has announced findings from a randomised, double-blind, double-dummy, multicentre Phase IV study showing that Prolia (denosumab) achieved greater gains...